Journal of translational medicine · 2026
A phenome-wide hunt for risk factors of Alzheimer's disease: from metabolic clues to neuroimaging evidence.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Dongming, Baranova Ancha, Sun Wenxi, Cao Hongbao, Zhang Bing, Zhang Fuquan, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium
Аннотация
BACKGROUND: This study systematically investigated phenotypes causally associated with Alzheimer's disease (AD) across the phenome and validated the findings at cognitive and neuroimaging levels using real-world clinical data.
METHODS: We performed phenome-wide Mendelian Randomization (MR) analyses on genetic proxies for over 860 disease phenotypes to identify traits causally associated with AD. Lipid metabolism-related phenotypes identified through MR were further examined in the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset to assess associations with AD risk, brain structure, and cognition.
RESULTS: MR analyses revealed a significant causal association between lipid metabolism, particularly low-density lipoprotein cholesterol (LDL-C), and the risk of AD (OR: 1.05, 95% CI: 1.03-1.07). In ADNI, higher LDL-C indicators correlated with increased AD risk, reduced hippocampal and entorhinal volumes, and poorer cognitive performance. Notably, elevated cholesterol-to-total lipid ratios in small LDL particles were negatively associated with the entorhinal-hippocampal complex. Among cognitively normal individuals, higher LDL-C indicators were associated with smaller hippocampus-amygdala transition area (HATA) and CA3 head volumes. In those with mild cognitive impairment, higher LDL-C was associated with reduced entorhinal surface area.
CONCLUSIONS: Our findings suggest that disrupted LDL-C metabolism may play a causal role in the development and progression of AD.
METHODS: We performed phenome-wide Mendelian Randomization (MR) analyses on genetic proxies for over 860 disease phenotypes to identify traits causally associated with AD. Lipid metabolism-related phenotypes identified through MR were further examined in the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset to assess associations with AD risk, brain structure, and cognition.
RESULTS: MR analyses revealed a significant causal association between lipid metabolism, particularly low-density lipoprotein cholesterol (LDL-C), and the risk of AD (OR: 1.05, 95% CI: 1.03-1.07). In ADNI, higher LDL-C indicators correlated with increased AD risk, reduced hippocampal and entorhinal volumes, and poorer cognitive performance. Notably, elevated cholesterol-to-total lipid ratios in small LDL particles were negatively associated with the entorhinal-hippocampal complex. Among cognitively normal individuals, higher LDL-C indicators were associated with smaller hippocampus-amygdala transition area (HATA) and CA3 head volumes. In those with mild cognitive impairment, higher LDL-C was associated with reduced entorhinal surface area.
CONCLUSIONS: Our findings suggest that disrupted LDL-C metabolism may play a causal role in the development and progression of AD.